Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Selective ALDH2 Inhibitor for the Treatment of Alcohol Use Disorder

NCT04311294 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT04311294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04311294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Selective ALDH2 Inhibitor for the Treatment of Alcohol Use Disorder
Lead sponsor
University of California, Los Angeles
Phase
Phase 2
Overall status
Withdrawn
Start date
April 30, 2020
Completion date
March 31, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder